Immunovant CLO Christopher Van Tuyl Exercises Options and Sells Shares

Immunovant, Inc. Chief Legal Officer Christopher Van Tuyl filed a Form 4 disclosing significant stock transactions on June 26, 2026. Van Tuyl exercised stock options to acquire 17,824 shares at $15.20 per share, while simultaneously selling 17,824 shares from his option exercise and an additional 14,982 shares at a weighted average price of $38.19. He also sold another 2,842 shares at a weighted average price of $38.96. Following these transactions, Van Tuyl's total common stock holdings decreased from 198,421 shares to 180,597 shares, while he still holds 53,707 stock options. The stock sales were executed at prices ranging from $37.75 to $39.15 per share, representing a substantial gain over the $15.20 exercise price. These transactions appear to be part of a routine exercise-and-sell strategy commonly employed by corporate executives to monetize stock options while maintaining significant equity positions in the company.